Published in Arch Immunol Ther Exp (Warsz) on January 05, 2010
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol (2012) 2.98
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev (2014) 2.45
Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci (2011) 1.57
Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37. Proc Natl Acad Sci U S A (2011) 1.48
ETosis: A Microbicidal Mechanism beyond Cell Death. J Parasitol Res (2012) 1.22
LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS One (2011) 1.08
Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii. MBio (2013) 1.05
High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta (2014) 1.05
Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair (2013) 0.99
Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability. Am J Physiol Cell Physiol (2010) 0.96
Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. PLoS One (2013) 0.94
Glutamine synthetase and glucose-6-phosphate isomerase are adhesive moonlighting proteins of Lactobacillus crispatus released by epithelial cathelicidin LL-37. J Bacteriol (2012) 0.94
The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacol Physiol (2012) 0.93
Innate immunity derived factors as external modulators of the CXCL12-CXCR4 axis and their role in stem cell homing and mobilization. Theranostics (2013) 0.93
Antimicrobial peptides and colitis. Curr Pharm Des (2013) 0.91
Nanomedicine as an emerging approach against intracellular pathogens. Int J Nanomedicine (2011) 0.91
The expanding family of bone marrow homing factors for hematopoietic stem cells: stromal derived factor 1 is not the only player in the game. ScientificWorldJournal (2012) 0.89
Cationic antimicrobial peptides serve as activation signals for the Salmonella Typhimurium PhoPQ and PmrAB regulons in vitro and in vivo. Front Cell Infect Microbiol (2012) 0.87
Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri. PLoS One (2011) 0.86
Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections. J Antimicrob Chemother (2012) 0.85
LL-37 induces polymerization and bundling of actin and affects actin structure. PLoS One (2012) 0.84
Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.83
Cathelicidin antimicrobial peptide expression is not induced or required for bacterial clearance during salmonella enterica infection of human monocyte-derived macrophages. Infect Immun (2012) 0.82
The Role of Cathelicidin LL-37 in Cancer Development. Arch Immunol Ther Exp (Warsz) (2015) 0.81
Massively parallel amplicon sequencing reveals isotype-specific variability of antimicrobial peptide transcripts in Mytilus galloprovincialis. PLoS One (2011) 0.81
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy. J Nanobiotechnology (2016) 0.80
The effect of light on critical illness. Crit Care (2011) 0.80
Effect of intracellular expression of antimicrobial peptide LL-37 on growth of escherichia coli strain TOP10 under aerobic and anaerobic conditions. Antimicrob Agents Chemother (2013) 0.80
Defensins and LL-37: a review of function in the gingival epithelium. Periodontol 2000 (2013) 0.79
Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells. Int J Nanomedicine (2015) 0.79
Cathelicidin, an antimicrobial peptide produced by macrophages, promotes colon cancer by activating the Wnt/β-catenin pathway. Oncotarget (2015) 0.79
Plasma Antimicrobial Peptide LL-37 Level Is Inversely Associated with HDL Cholesterol Level in Patients with Type 2 Diabetes Mellitus. Int J Endocrinol (2014) 0.78
Expression of the ATP-gated P2X7 Receptor on M Cells and Its Modulating Role in the Mucosal Immune Environment. Immune Netw (2015) 0.76
Chronic Ethanol Exposure Effects on Vitamin D Levels Among Subjects with Alcohol Use Disorder. Environ Health Insights (2016) 0.76
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? Clin Rheumatol (2015) 0.76
Core-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins. Int J Nanomedicine (2016) 0.75
Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection. Antimicrob Agents Chemother (2015) 0.75
Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells. Mol Med Rep (2016) 0.75
Gonorrhea - an evolving disease of the new millennium. Microb Cell (2016) 0.75
High therapeutic efficacy of Cathelicidin-WA against postweaning diarrhea via inhibiting inflammation and enhancing epithelial barrier in the intestine. Sci Rep (2016) 0.75
Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites. PLoS One (2016) 0.75
Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus. J Oral Microbiol (2014) 0.75
Antimicrobial peptide LL-37 promotes the proliferation and invasion of skin squamous cell carcinoma by upregulating DNA-binding protein A. Oncol Lett (2016) 0.75
Blastocystis Isolate B Exhibits Multiple Modes of Resistance against Antimicrobial Peptide LL-37. Infect Immun (2016) 0.75
Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1. Exp Ther Med (2017) 0.75
Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem (2003) 1.85
Hybrid cardiovascular procedures in the treatment of selected congenital heart disease in children: a single-centre experience. Kardiol Pol (2013) 1.20
Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice. BMC Microbiol (2009) 0.94
Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa. J Immunol (2011) 0.89
Fluoride release and antibacterial activity of selected dental materials. Postepy Hig Med Dosw (Online) (2006) 0.88
Antimicrobial activity of Potentilla species. Fitoterapia (2008) 0.84
Modulation of exogenous antibiotic activity by host cathelicidin LL-37. APMIS (2010) 0.84
Fatty acid- and cholesterol transporter protein expression along the human intestinal tract. PLoS One (2010) 0.83
Composition of the essential oil of Bidens tripartita L. roots and its antibacterial and antifungal activities. J Med Food (2011) 0.83
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate. Antimicrob Agents Chemother (2010) 0.81
Ozone in dentistry: microbiological effects of gas action depending on the method and the time of application using the ozonytron device. Experimental study. Ann Acad Med Stetin (2011) 0.81
Effect of complex cardiac rehabilitation on physical activity and quality of life during long-term follow-up after surgical correction of congenital heart disease. Kardiol Pol (2014) 0.81
Histological assessment of myocardium in lethal ethanol intoxication. Kardiol Pol (2015) 0.77
Are Lewis b and H type 1 on Helicobacter pylori involved in binding of bacteria to MUC1 mucin? Adv Clin Exp Med (2013) 0.76
Antibacterial activity of two Mineral Trioxide Aggregate materials in vitro evaluation. Ann Acad Med Stetin (2008) 0.76
Assessment of interactions between mucins of gastric juice and Helicobacter pylori--preliminary study. Hepatogastroenterology (2010) 0.75
[Adaptation of immunoenzymatic method for detection of antibody coated bacteria in urine]. Med Dosw Mikrobiol (2004) 0.75
Histological assessment of myocardium in lethal ethanol intoxication. Kardiol Pol (2015) 0.75
[Assessment of thyroid function in women treated for vomiting in early pregnancy]. Ginekol Pol (2005) 0.75
[Sanfetrinem, the member of trinems--in vitro activity against Klebsiella pneumoniae producing ESBL]. Med Dosw Mikrobiol (2006) 0.75
[Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens]. Med Dosw Mikrobiol (2004) 0.75
Inflammatory marker levels after hybrid treatment of selected congenital heart disease in children. Kardiol Pol (2014) 0.75
[Analysis of pregnancy, labor and neonatal course in babies with prenatally-diagnosed complete atrioventricular heart block]. Ginekol Pol (2015) 0.75
Comparison of fetal myocardial contractility before and after laser photocoagulation of communicating vessels in twin-to-twin transfusion syndrome. Ginekol Pol (2014) 0.75
Outpatient use of systemic antibiotics in Poland: 2004-2008. Przegl Epidemiol (2014) 0.75
SUBGALEAL HEMATOMA AS A PERINATAL PRESENTATION OF RARE HEMATOLOGIC PROBLEMS IN NEWBORNS. OWN EXPERIENCE. Dev Period Med (2016) 0.75
[The application of immunoperoxidase test for the detection of antibodies various classes (IgA, IgG and IgM) coating bacteria in urine]. Med Dosw Mikrobiol (2005) 0.75
[Myomas and pregnancy--obstetrics dilemma of the next decade?]. Ginekol Pol (2002) 0.75
[Cranial ultrasound through posterolateral fontanelle in visualization of posterior fossa abnormalities in preterm and term neonates]. Ginekol Pol (2015) 0.75
[The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods]. Med Dosw Mikrobiol (2006) 0.75
[Women's knowledge of health behaviors in the puerperium]. Wiad Lek (2004) 0.75
[The relationship between course of pregnancy and health condition of the newborn]. Wiad Lek (2002) 0.75
[Pregnancy, delivery and puerperium in patients after liver transplantation]. Ginekol Pol (2003) 0.75